12/23
06:50 am
krys
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? [Yahoo! Finance]
Low
Report
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? [Yahoo! Finance]
12/18
01:19 pm
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Medium
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
12/18
08:14 am
krys
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
12/18
08:07 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
Medium
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
12/18
08:00 am
krys
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
Medium
Report
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
12/12
01:07 pm
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
12/12
08:00 am
krys
Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels
Medium
Report
Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels
12/10
08:00 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
Medium
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
12/9
04:15 pm
krys
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
Low
Report
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
12/4
01:28 pm
krys
Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? [Yahoo! Finance]
11/29
12:04 pm
krys
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
11/27
07:09 am
krys
Krystal Biotech to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Krystal Biotech to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/27
07:00 am
krys
Krystal Biotech to Present at Upcoming Investor Conferences
Low
Report
Krystal Biotech to Present at Upcoming Investor Conferences
11/12
07:00 am
krys
Krystal Biotech to Present at Stifel 2024 Healthcare Conference
Medium
Report
Krystal Biotech to Present at Stifel 2024 Healthcare Conference
11/7
08:25 am
krys
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]
Low
Report
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]
11/6
07:00 am
krys
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
Medium
Report
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
11/5
10:41 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $204.00 to $206.00. They now have a "neutral" rating on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $204.00 to $206.00. They now have a "neutral" rating on the stock.
11/5
09:43 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $221.00 price target on the stock.
11/5
06:13 am
krys
Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
Low
Report
Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
11/5
02:14 am
krys
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/4
08:00 am
krys
Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates
Medium
Report
Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates
10/28
11:40 am
krys
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth [Yahoo! Finance]
Low
Report
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth [Yahoo! Finance]
10/28
07:00 am
krys
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
Low
Report
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
10/18
01:48 pm
krys
All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy [Yahoo! Finance]